More than a news roundup 

This is not a feed to scroll or another digest to skim. Every edition is drawn from the editorial teams behind Scrip, Pink Sheet, In Vivo, Medtech Insight, Generics Bulletin and HBW Insight: more than a century of biopharma reporting, distilled into the developments that actually matter. No noise. One read. Plus an audio edition for the days you'd rather listen. 

Your week, one theme at a time 

• Monday sets up the week and reads what moved over the last one. 
• Tuesday goes inside the trial data: what it says against what the company claimed. 
• Wednesday takes the regulators: FDA, EMA, MHRA. 
• Thursday goes deep on one therapeutic area. 
• Friday steps back for the longer view. 

Start your morning ahead 

Six minutes a day, and you walk into every meeting, raise, and decision knowing what moved and why it matters. Capsul is free to read for a limited time, sign up now and start with the next edition.